671 related articles for article (PubMed ID: 28903781)
1. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis.
Sheng L; Stewart T; Yang D; Thorland E; Soltys D; Aro P; Khrisat T; Xie Z; Li N; Liu Z; Tian C; Bercow M; Matsumoto J; Zabetian CP; Peskind E; Quinn JF; Shi M; Zhang J
Acta Neuropathol Commun; 2020 Jul; 8(1):102. PubMed ID: 32641150
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.
Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J
J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594
[TBL] [Abstract][Full Text] [Related]
4. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
Matsumoto J; Stewart T; Banks WA; Zhang J
Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
[TBL] [Abstract][Full Text] [Related]
5. C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein.
Amagai R; Otomo R; Yoshioka S; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
J Biochem; 2024 May; 175(6):649-658. PubMed ID: 38308089
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
7. Microglia as modulators of exosomal alpha-synuclein transmission.
Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
[TBL] [Abstract][Full Text] [Related]
9. Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells.
Gustafsson G; Lööv C; Persson E; Lázaro DF; Takeda S; Bergström J; Erlandsson A; Sehlin D; Balaj L; György B; Hallbeck M; Outeiro TF; Breakefield XO; Hyman BT; Ingelsson M
Cell Mol Neurobiol; 2018 Nov; 38(8):1539-1550. PubMed ID: 30288631
[TBL] [Abstract][Full Text] [Related]
10. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
Zhang S; Eitan E; Wu TY; Mattson MP
Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from patients with Parkinson's disease are pathological in mice.
Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
[TBL] [Abstract][Full Text] [Related]
12. Alpha synuclein is transported into and out of the brain by the blood-brain barrier.
Sui YT; Bullock KM; Erickson MA; Zhang J; Banks WA
Peptides; 2014 Dec; 62():197-202. PubMed ID: 25278492
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
[TBL] [Abstract][Full Text] [Related]
14. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
Miao Y; Meng H
Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
[TBL] [Abstract][Full Text] [Related]
15. Polarized α-synuclein trafficking and transcytosis across brain endothelial cells via Rab7-decorated carriers.
Alam P; Holst MR; Lauritsen L; Nielsen J; Nielsen SSE; Jensen PH; Brewer JR; Otzen DE; Nielsen MS
Fluids Barriers CNS; 2022 May; 19(1):37. PubMed ID: 35637478
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of the erythrocyte miR-451a in brain extracellular vesicles following impairment of the blood-brain barrier.
Koopaei NN; Chowdhury EA; Jiang J; Noorani B; da Silva L; Bulut G; Hakimjavadi H; Chamala S; Bickel U; Schmittgen TD
Neurosci Lett; 2021 Apr; 751():135829. PubMed ID: 33727125
[TBL] [Abstract][Full Text] [Related]
17. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
Herman S; Djaldetti R; Mollenhauer B; Offen D
Brain; 2023 Jan; 146(1):209-224. PubMed ID: 35881523
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier
Morad G; Carman CV; Hagedorn EJ; Perlin JR; Zon LI; Mustafaoglu N; Park TE; Ingber DE; Daisy CC; Moses MA
ACS Nano; 2019 Dec; 13(12):13853-13865. PubMed ID: 31479239
[TBL] [Abstract][Full Text] [Related]
19. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Alpha-Synuclein is Essential for the Transfer of Pathology by Exosome-Enriched Extracellular Vesicles, Following Inoculation with Preformed Fibrils in vivo.
Melachroinou K; Divolis G; Tsafaras G; Karampetsou M; Fortis S; Stratoulias Y; Papadopoulou G; Kriebardis AG; Samiotaki M; Vekrellis K
Aging Dis; 2024 Apr; 15(2):869-892. PubMed ID: 37548944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
